{"id":"W2582331875","doi":"10.1182/blood.v116.21.2886.2886","title":"Evaluation of CPX-351 (cytarabine:daunorubicin) Liposome Injection Anti-Leukemic Activity Against Primary Patient Leukemia Cells","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Leukemia; Cytarabine; Medicine; Daunorubicin; Myeloid leukemia; Acute lymphocytic leukemia; Chronic lymphocytic leukemia; Bone marrow; Immunology; Myeloid; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001745345,0.0003104299,0.0005801551,0.0003413941,0.0001089063,0.0000266227,0.0002148195,0.0003596274,0.0001707816],"category_scores_gemma":[0.0005541909,0.0002838148,0.0002035269,0.0005512782,0.0002147118,0.0002436809,0.0001647586,0.0008119026,0.0001070341],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.00982643,"about_ca_system_score_gemma":0.01709159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008751384,"about_ca_topic_score_gemma":0.00008833836,"domain_scores_codex":[0.9956895,0.000255545,0.0005614226,0.0006009075,0.002339362,0.000553339],"domain_scores_gemma":[0.9972662,0.0001812109,0.0003151703,0.00100971,0.0009704529,0.00025723],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002066164,0.00123318,0.0008026634,0.0002926056,0.000217226,0.00003203649,0.000366968,0.0004216757,0.9454068,0.000008417115,0.000318426,0.05069338],"study_design_scores_gemma":[0.03451029,0.0007857673,0.02361118,0.0001896605,0.0009383349,0.00026301,0.0000621448,0.02002735,0.9189366,0.00005866893,0.0003040205,0.0003129714],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909465,0.0002113297,0.00002000082,0.0000554729,0.0006397916,0.001428102,0.00002162816,0.0001059615,0.006571201],"genre_scores_gemma":[0.9986123,0.0001080124,0.0003769181,0.0001166285,0.0003833633,0.00008020903,0.00006309665,0.0000631025,0.0001963977],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05038041,"threshold_uncertainty_score":0.9999614,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01776896138947283,"score_gpt":0.2770523405404978,"score_spread":0.259283379151025,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}